Form 4 for BSX Boston Scientific
Accepted 2024-12-02 00:00:00 ET · period of report 2024-11-27 · accession 0001225208-24-010326 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-02 | 2024-11-27 | BSX | Woodworth Emily | SVP, CAO, Gbl Ctrl | S - Sale | $90.65 | -1,336 | 2,957 | -31% | -$121.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-27 | S | D | 1,336 | $90.65 | 2,957 | D | — | — | (F1) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $90.6202 to $90.6538, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F2) Includes shares acquired on June 30, 2024 under the Company's Employee Stock Purchase Plan based upon the most current data available. |